Microcrystalline Cellulose Market to Reach USD 2.61 Billion by 2035, Owing to Demand for Natural Excipients and Clean-Label Ingredients | SNS Insider

The Microcrystalline Cellulose Market is expanding as industries shift toward plant-based, sustainable ingredients, with the U.S. segment growing from USD 0.37 billion in 2025 to USD 0.75 billion by 2035.

Austin, April 01, 2026 (GLOBE NEWSWIRE) — The Microcrystalline Cellulose Market size was estimated at USD 1.30 billion in 2025 and is expected to reach USD 2.61 billion by 2035, growing at a CAGR of 7.23% over the forecast period (2026-2035).

The growth of the market is driven by increasing pharmaceutical solid dosage form production, expanding clean-label food and beverage formulation requirements, and consumer preference for plant-derived functional ingredients.

Download PDF Sample of Microcrystalline Cellulose Market @ https://www.snsinsider.com/sample-request/8098

The U.S. Microcrystalline Cellulose Market was valued at USD 0.37 billion in 2025 and is expected to reach USD 0.75 billion by 2035, growing at a CAGR of 7.31%.  

Due in significant part to its well-established pharmaceutical solid dosage manufacturing base, high per-capita use of dietary supplements, and sophisticated infrastructure for processing food ingredients, the United States is the largest market for microcrystalline cellulose.

Expanding Pharmaceutical Solid Dosage Form Production to Boost Growth Globally

The growing global volume of tablet and capsule production, patent expiry-driven generic drug launch pipelines, and pharmaceutical manufacturer preference for USP/NF-grade excipients with established regulatory acceptance across major drug approval jurisdictions are the main factors driving the growth of the microcrystalline cellulose market share. The need for pharmaceutical-grade and food-grade cellulose excipients is being driven by these tablet compression performance and medicinal product stability solutions, which are also increasing the market’s base and global market share.

Segmentation Analysis:

By Source

The wood-based segment accounted for the highest revenue share of approximately 72.34% in 2025, owing to the well-established dissolving-grade wood pulp supply chains globally. The non-wood-based segment is anticipated to achieve the highest CAGR of nearly 8.46% during the 2026–2035 period, driven by the increasing availability of agricultural residue feedstocks including cotton linters, sugarcane bagasse, and rice straw for cellulose extraction globally.

By Application

The pharmaceutical segment accounted for the largest share of the microcrystalline cellulose market with about 54.67% and is also expected to grow at the fastest rate with a CAGR of around 7.58% throughout the forecast period of 2026–2035 owing to the near-universal use of microcrystalline cellulose as a binder, disintegrant, and filler in solid oral dosage form manufacturing globally.

If You Need Any Customization on Microcrystalline Cellulose Market Report, Inquire Now @ https://www.snsinsider.com/enquiry/8098

Regional Insights:

With a CAGR of 8.62%, Asia Pacific is the microcrystalline cellulose market’s fastest-growing region due to rising awareness of pharmaceutical-grade excipient quality standards, an increase in the volume of generic drug manufacturing, and the modernization of food ingredient processing infrastructure in the economies of China, India, and Southeast Asia.

Due to an established pharmaceutical manufacturing base, strict FDA excipient GMP compliance requirements, and increased formulator awareness of the functional performance advantages of pharmaceutical- and food-grade microcrystalline cellulose, North America held the largest revenue share of the microcrystalline cellulose market in 2025, which is more than 36.48%.

Key Players:

• DuPont de Nemours, Inc. (Nutrition & Biosciences)
• Asahi Kasei Corporation
• Mingtai Chemical Co., Ltd.
• JRS Pharma GmbH & Co. KG
• Roquette Frères S.A.
• Sigachi Industries Limited
• Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
• Wei Ming Pharmaceutical Mfg. Co., Ltd.
• Blanver Farmoquimica e Farmaceutica Ltda.
• Avantor, Inc.
• Merck KGaA (MilliporeSigma)
• Celanese Corporation
• Biogrund GmbH
• Accent Microcell Pvt. Ltd.
• Prachin Chemical Pvt. Ltd.
• Huzhou Zhanwang Pharmaceutical Co., Ltd.
• Juku Orchem Private Limited
• Dfe Pharma GmbH & Co. KG
• Thorlakson Holdings Ltd. (Tembec)
• Sappi Limited

Recent Developments:

In October 2024, DuPont de Nemours, Inc. expanded its Avicel® co-processed microcrystalline cellulose product line with two new grades optimized for direct compression tablet manufacturing at high-speed production rates, aiming to improve tablet hardness uniformity and reduce capping defect rates across pharmaceutical and nutraceutical customer formulations.

In March 2025, Asahi Kasei Corporation launched the Ceolus™ KG series of high-functionality microcrystalline cellulose grades targeting moisture-sensitive drug formulations and high-dose tablet production, announcing expanded technical support services for pharmaceutical CDMO customers across India and Southeast Asia.

Buy Full Research Report on Microcrystalline Cellulose Market 2026-2035 @ https://www.snsinsider.com/checkout/8098

Exclusive Sections of the Report (The USPs):

• Pharmaceutical Excipient Consumption & Formulation Adoption Metrics – helps you understand MCC consumption across solid dosage production, excipient-to-API ratios, and adoption of co-processed grades among leading drug manufacturers.
• Raw Material Sourcing & Sustainability Compliance Metrics – helps you evaluate feedstock sourcing trends, cost comparisons between wood and non-wood cellulose, and sustainability benchmarks including FSC/PEFC certification and carbon footprint analysis.
• Regulatory Compliance & Quality Standards Metrics – helps you track adherence to global pharmacopeia standards (USP/NF, Ph. Eur., JP), DMF filings, GMP audit performance, and food-grade compliance with EFSA and JECFA guidelines.
• Application Performance & Functional Benchmarking Metrics – helps you assess MCC performance in tablets, food systems, and personal care applications through tensile strength, disintegration time, and stability comparisons.
• Procurement Pricing & Supply Structure Metrics – helps you analyze regional pricing trends by grade and understand supply dynamics influencing procurement strategies.
• Multi-Industry Utilization & Specification Variance Metrics – helps you identify differences in particle size, bulk density, and formulation requirements across pharmaceutical, food, and cosmetic applications.

Read Other Related Reports:

Carboxymethyl Cellulose Market

Plant-based Excipients Market

Superdisintegrants Market

Hydroxyethyl Cellulose Market

Pharmaceutical Grade Lactose Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaEveningPost.com takes no editorial responsibility for the same.